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Abstract.  We previously demonstrated (Ookata et al., 
1992,  1993) that the p34~¢2/cyclin B complex associ- 
ates with microtubules in the mitotic spindle and 
premeiotic aster in starfish oocytes, and that 
microtubule-associated proteins (MAPs) might be 
responsible for this interaction.  In this study, we have 
investigated the mechanism by which p34  ~dc2 kinase as- 
sociates with the microtubule cytoskeleton in primate 
tissue culture cells whose major MAP is known to be 
MAP4.  Double staining of primate cells with anti- 
cyclin B and anti-MAP4 antibodies demonstrated these 
two antigens were colocalized on microtubules and 
copartitioned following two treatments that altered 
MAP4 distribution.  Detergent extraction before fixa- 
tion removed cyclin B as well as MAP4 from the 
microtubules.  Depolymerization of some of the cellu- 
lar microtubules with nocodazole preferentially re- 
tained the microtubule localization of both cyclin B 
and MAP4. The association of p34~d~Vcyclin B kinase 
with microtubules was also shown biochemically to be 
mediated by MAP4.  Cosedimentation of purified 
p34cdc2/cyclin B with purified microtubule proteins con- 
taining MAP4, but not with MAP-free microtubules, 
as well as binding of MAP4 to GST-cyclin B fusion 
proteins,  demonstrated an interaction between cyclin B 
and MAP4.  Using recombinant MAP4 fragments,  we 
demonstrated that the Pro-rich C-terminal  region of 
MAP4 is sufficient to mediate the cyclin B-MAP4 in- 
teraction.  Since p34~cVcyclin  B physically associated 
with MAP4, we examined the ability of the kinase 
complex to phosphorylate MAP4.  Incubation of a ter- 
nary complex of p34  ~c2, cyclin B, and the COOH- 
terminal domain of MAP4, Phu, with ATP resulted in 
intracomplex  phosphorylation of PA4. Finally, we tested 
the effects of MAP4 phosphorylation on microtubule dy- 
namics.  Phosphorylation of MAP4 by p34  ~d~2 kinase did 
not prevent its binding to microtubules, but abolished 
its microtubule stabilizing activity. Thus, the cyclin 
B/MAP4 interaction we have described may be impor- 
tant in targeting the mitotic kinase to appropriate 
cytoskeletal substrates,  for the regulation of spindle 
assembly and dynamics. 
p 
ROGaESSION through M-phase of the cell cycle is con- 
trolled by M-phase promoting factor (MPF) i, which 
consists  of a  complex of p34  cd~2 and  cyclin  B  (for 
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1. Abbreviations  used in this paper: CBB, Coomassie brilliant blue; MPE 
M-phase-promoting factor; MAP, microtubule-associated  protein. 
reviews  see Kishimoto,  1988;  Hunt,  1989;  Murray  and 
Kirschner,  1989; Nurse,  1990; Mailer,  1991). The complex 
displays histone HI kinase activity  specifically at the onset 
of mitosis.  Active  p34  c~2  kinase  is  required  to  generate 
many M-phase-specific events, including chromosome con- 
densation,  nuclear envelope breakdown, and reorganization 
of the microtubule network.  While the mechanism by which 
p34  cdc2 kinase  is activated  at mitosis has been extensively 
studied in recent years (see Mailer,  1991), relatively little is 
known  about  the  spatial  targeting  of p34  cdc2 kinase  that 
gives rise to these M-phase-specific events. 
The localization  of p34  c~2 kinase  is  known  to be regu- 
lated before mitosis,  and may be important for its action at 
the  G2/M  transition.  For  example,  a  portion  of  the 
p34~c2/cyclin B complex has been reported to translocate 
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lope breakdown (Pines and Hunter, 1991; Bailly et al., 1992; 
Gallant and Nigg, 1992; Ookata et al., 1992), while another 
portion  accumulates  at  asters  in  the  cytoplasm  (Maldo- 
nado-Codina and Glover,  1992;  Ookata et al.,  1992).  In 
metaphase cells, p34cd°2/cyclin  B is shown to concentrate in 
mitotic spindles (Rattner et al.,  1990;  Pines and Hunter, 
1991; Tombes et al., 1991; Maldonado-Codina and Glover, 
1992; Ookata et al., 1992).  In the nucleus, p34  cdc2 kinase is 
involved in chromosome condensation, by phosphorylating 
histone H1 and other proteins, as well as in nuclear envelope 
breakdown, by phosphorylating nuclear lamins (Heald and 
McKeon,  1990;  Peter et al.,  1990;  Ward and Kirschner, 
1990;  Luscher et al.,  1991; Ohsumi et al.,  1993).  In addi- 
tion, p34  ~c2 kinase associated with asters and mitotic spin- 
dles may be involved in the rearrangement of  the microtubule 
network at mitosis, by phosphorylating centrosomal proteins 
(Ballly et al.,  1989; Riabowol et al.,  1989; Buendia et al., 
1992;  Ohta et al.,  1993).  It may also be involved in the 
change of microtubule dynamics at the onset of mitosis, by 
phosphorylating microtubule-associated proteins (Belmont 
et al., 1990; Verde et al., 1990; Ookata et al., 1993). How- 
ever, except for nuclear lamins, whose filaments are disas- 
sembled by phosphorylation with cdc2 kinase, no clear evi- 
dence indicating a functional relationship between M-phase 
events and phosphorylation of p34  c°c2 kinase substrates has 
been obtained. 
In this study, we have focused our attention on the regula- 
tion of microtubule dynamics at mitosis, concentrating on 
the following questions: (a) How does p34  ~dc~ kinase associ- 
ate with asters and spindles? (b) Is any microtubule protein 
substrate(s) phosphorylated by p34  ¢d~2 kinase in vivo and/or 
in vitro? (c) If so, how does this phosphorylation contribute 
to alteration of microtubule dynamics during mitosis? To be- 
gin to address these questions, we previously used starfish 
oocytes, and demonstrated that the p34°d~Vcyclin  B complex 
associated with microtubules via binding to MAPs (Ookata 
et al., 1993). However, in starfish oocytes we could not read- 
ily  identify microtubule-associated  proteins  (MAPs)  as- 
sociated with p34¢~cVcyclin  B. To analyze the mechanism by 
which p34c~2/cyclin B associates with microtubules, then, 
we chose HeLa cells, because they are typical proliferating 
cells showing cyclic activation of p34  ~d'2 kinase at mitosis 
(Draetta and Beach, 1988), and their MAP composition has 
been analyzed previously. HeLa MAPs consist mainly of a 
heat stable 210-kD MAP (MAP4), although a 125-kD MAP 
has  also  been  detected  (Bulinski  and  Borisy,  1980a; 
Weatherbee et al.,  1982;  Murofushi et al.,  1987; Bulinski 
and  Bossler,  1994).  MAP4  is  the  most abundant,  well- 
characterized MAP in proliferating cultured cells (reviewed 
by Olmsted, 1986; Vallee,  1990).  Moreover, blotting with a 
monoclonal antibody  (MPM2)  that recognizes  M-phase- 
specific phosphoproteins has demonstrated that HeLa MAP4 
is phosphorylated at mitosis (Vandre et al.,  1991). 
Double  immunostaining of primate cultured cells with 
anti-cyclin B and anti-MAP4 antibodies showed correlation 
of their distributions under several  conditions, suggesting 
that binding of the p34  ~d~2 kinase complex to microtubules 
occurs in a MAP4-dependent manner. We report here that 
p34  ~d~2 kinase  associates  with  microtubules  through  the 
binding of cyclin B  to the proline-rich  region of MAP4. 
HeLa MAP4  associated  with p34  ¢d~2 kinase  in  vitro  was 
phosphorylated by the kinase complex.  Darkfield micros- 
copy of single microtubules demonstrated that this level of 
phosphorylation altered the dynamics of MAP4-stabilized 
microtubules. 
Materials and Methods 
Cell Culture and Synchronization 
HeLa cells (strain $3) were cultured as a monolayer at 37°C in DME sup- 
plemented with 5% fetal calf serum. Cells were synchronized at the G1/S 
boundary by treatment with 2.5 mM thymidine for 24 h. 8 h after wash out 
of the thymidine to release the block, cells were treated with 0.4/~g/ml 
nocodazole for 5 h and mitotic cells were collected. African green monkey 
kidney cells (TC-7 line) were cultured as described previously (Bulinski and 
Boris),,  1980b). 
Preparation of  MAP4, Tubulin and 
p34~c2/cyclin B Kinase 
Microtubules were polymerized with the aid oftaxol (20/zM) in the mitotic 
HeLa cell extract and sedimented through a  10%  sucrose cushion, essen- 
tially as described by VaUee (1982). 
Crude HeLa MAP4 was prepared by boiling a MAP fraction elnted from 
microtubules with 0.5 M NaCl (Vallee,  1982). Purified MAP4 was prepared 
by one more cycle of microtubule-binding and heat treatment of the crude 
MAP4.  Bovine MAP4  was  purified  from  adrenal  cortex  according to 
Murofushi et al. (1986). 
Microtubule protein was prepared from porcine brains by two cycles of 
temperature-dependent polymerization/depolymerization  (Shelanski et al., 
1973).  Tubulin was purified from microtubules by either phosphocellulose 
or DEAE-cellulose column chromatography (Murphy and Borisy,  1975; 
Weingarten et al.,  1975). 
The expression of MAP4 fragments in Escherichia coil strain MM294 
and their purification were performed according to Aizawa et al. (1991a). 
Cyclin B-dependent p34  cdc2 kinase was purified from starfish oocytes at 
the first meiotic M-phase by p13  sucl affinity chromatography; p34Cde2/cyclin 
B  complex  was  eluted  from  the  column  with  0.5  M  NaCl  and  50% 
ethyleneglycol (Kusubata et al., 1992;  Ookata et al., 1993;  Okumura and 
Kishimoto, manuscript in preparation). 
Preparation of GST-fusion Proteins and Conjugation 
to GSH-Sepharose 4B-beads 
GST-cyclin  B- and GST-cyclin  D-immobilized Sepharose beads were pre- 
pared as follows: A 1.4-kb BamHI fragment of starfish cyclin B cDNA, en- 
coding amino acids 3%396 (Tachibana et al.,  1990)  was ligated in frame 
to the unique BamHI site of pGEX-2T (Pharmacia LKB Nuclear, Gaithers- 
burg, MD). A 1.1-kb EcoRI fragment of cyclin D2 cDNA, encoding amino 
acids 2%289 (Tachibana  et al., unpublished data) was ligated in frame to 
the unique EcoRI site of pGEX-2T. 
Cultures ofE. coli JM109 transformed with DGEX-Zlr plasmids contain- 
ing either cyclin B or cyclin D2 cDNA were diluted 1:10 in 400 ml of fresh 
LB medium (10 g/l NaCI, 10 g/1 Bactotryptone, 5 g/1 yeast extract, pH 7.2) 
containing ampicillin (150  /~g/mi) and  incubated for 4  h.  After  1 h  of 
growth, isopropyl-l-thio-/3-D-galactopyranoside (TAKARA shuzo, Japan) 
was added to a final concentration of 1 raM. Bacterial cultures were cen- 
trifuged and the resulting bacterial pellet was resuspended in 40 mi of 100 
mM NaCl, 1 mM EDTA, 20 mM Tris-HCl, pH 8.0, and 0.5 % Nonidet P-40 
(NETN).  The cells were lysed on ice by mild sonication and centrifuged 
at 27,000 g for 1 h at 4°C. The supernatant was mixed at 4°C in a 50 ml 
polypropylene tube on rotating platform with 1 rrd glntathione-Sepharose- 
beads, which had been previously washed three times and resuspended 
(final concentration l:l [vol/vol]) in NETN. After adsorption for 1 h, beads 
were collected by centrifugation at 500 g and washed three times with 50 
ml NETN.  There are more amounts of cyclin D  compared with cyclin B 
on the beads. 
GST-cyclin-Beads Binding Assay 
HeLa MAP4 (10/~g/ml) or expressed bovine MAP4 fragments (5 t~g/ml) 
were incubated with GST-cyclin  B or D-beads in 20 mM Pipes, pH 6.8, 1 
mM MgSO4,  1 mM EGTA, 0.1  M  NaCI, and 0.1% Nonidet P-40 for 20 
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and suspended in SDS-sample buffer after washing three times with the 
above binding buffer.  The association of MAP4 with beads was analyzed 
by immunoblot with anti-MAP4 antibody (Murofushi et al.,  1987). 
Microtubule Binding Assay 
Microtubules were polymerized from purified brain tubulin (0.9 mg/ml) 
with 20 #M taxol and 0.5 mM GTP in the presence or absence of MAP4 
(28 /Lg/ml). The purified starfish p34¢aC2/cyclin B complex (,~10/zg/ml) 
was added to the microtubule suspension and incubated at 30"C for 10 rain. 
The bound p34Cze2/cyclin  B complex was separated from unbound material 
by sedimentation of microtubules, and cyclin B was detected in supernatant 
and pellet by immunoblotting with anti-starfish cyclin B antibody (Ookata 
et ai., 1992). The amount of cyclin B associated with microtubules was esti- 
mated by densitometric scanning (ACI-Japan, Tokyo, Japan) of the cyclin 
B band, detected by immunoblotting. 
Kinase Assay 
Microtubule-associated kinase activity was measured with or without his- 
tone H1 (0.2 mg/ml) as an external substrate, in a reaction mixture consist- 
ing of 0.1 M Pipes, pH 6.8,  1 mM EGTA, and 1 mM MgCI2 (PEM), and 
0.5 mM [,t-32P]ATP in the presence or absence of cAMP-dependent pro- 
tein kinase inhibitor (5/zg/ml) for 15 rain at 30°C. The reaction was stopped 
by adding SDS-sample buffer.  For some experiments, the reaction was 
stopped by boiling for 5 rain in 0.5 M NaCI, and the heat-stable MAP4 was 
recovered in the supernatant fraction following centrifugation at 100,000 g 
for 30 min. Proteins were separated on 5-15 or 8 % polyacrylarnide gradient 
SDS-PAGE followed by autoradiography on Kodak X-MAT x ray film. 
To immunodeplete p34Cae2/cyclin B complex, the 0.5 M NaCl-extracted 
MAP4 fraction was dialyzed against 20 mM Pipes, pH 6.9, 50 mM NaCI, 
1 mM MgCI2,  1 mM EGTA, and 0.1% Triton X-100, mixed with 15 t~l of 
anti-human cyclin B antibody prebound to protein A-Sepharose beads, and 
incubated for 30 rain at 4"C. The supernatant fraction following centrifuga- 
tion at 3,000 g  for 2 min was used to assess phosphorylation of MAP4. 
The crude MAP4 (50-110 t~g/mi) was phosphorylated by starfish oocyte 
p34~  kinase (5 ~,g/ml) in PEM at 30"C  for 60 min. The reaction was 
stopped by addition of SDS-sample buffer and the samples were analyzed 
on 5-15 % polyacrylamide SDS-PAGE. The level of incorporated phosphate 
was estimated by Cerenkov radiation of excised MAP4 bands. The amount 
of MAP4 was estimated by densitometric scanning of the gel stained with 
Coomassie brilliant blue (CBB), using BSA as a standard. Molecular mass 
of HeLa MAP4 was estimated to be 110 kD, according to the sequence data 
of bovine MAP4 (Aizawa et ai.,  1990). 
The purified p34CaC2/cyclin B complex was bound to pl3~UC~-conjugated 
Sepharose-beads by incubation in Buffer A  (80 mM Na-/~-glycerophos- 
phate, 20 mM EGTA, 15 mM MgCI2,  1 mM dithiothreitol, pH 7.3) for 30 
min at 4°C (Ookata et al.,  1992).  After washing with Buffer A, the PA4 
fragment of bovine MAP4 (0.17 mg/ml; see diagram in Fig. 5 for terminol- 
ogy) was added and incubated in PEM at 4°C for 30 rain. Unbound PA4 
was removed by washing twice with 20 mM Pipes, pH 6.8, 100 mM NaCI, 
0.1% Nonidet P-40 containing 1 mg/ml bovine serum albumin, and once 
with PEM. PA4 was phosphorylated by incubating with 0.2 mM [~_32p]_ 
ATP at 30°C for 60 min and the reaction was stopped by the addition of 
SDS-sample buffer.  The samples were boiled for 2  min and centrifuged 
briefly to remove Sepharose beads. The supernatants were electrophoresed 
on 10%  SDS-PAGE and autoradiographed. 
Observation of  Microtubule Dynamics 
The crude MAP4 (100/zg/ml) or purified MAP4 (31  pg/ml) was phos- 
phorylated at 30°C for 60 rain with starfish p34  cdc2 kinase. To inactivate 
and remove p34  cat2 kinase following this incubation, the reaction mixture 
was boiled for 3 rain after addition of 0.5 M NaCl. After centrifugation at 
100,000 g for 30 rain, the supernatant was dialyzed against PEM and used 
as phosphorylated MAP4. 
Micrombule  dynamics  were  analyzed by  monitoring the  Change  in 
microtubule length from the images recorded on videotapes, by the proce- 
dure described previously (Horio and Hotani,  1986) with some modifica- 
tions. Brain MAPs were shown to stabilize microtubules under the same 
conditions used here for MAP4 (ltob and Hotani,  1994).  Briefly,  50 ~1 of 
tubulin (3.7 mg/ml) was incubated at 37°C for 5 rain to allow polymerization 
of microtubules. Prewarmed MAP4 was added to the micrombule solution, 
and 5 t~l was immediately transferred to a glass slide. And then, microtu- 
bules were observed at room temperature (24-26°C). The final tubulin and 
MAP concentrations were about 1.8 mg/ml and 0 to 50 t~g/ml, respectively. 
The change in length at each end of a given micrombule was followed by 
determining the distance between each end and an arbitrary fixed point on 
the microtubule as a function of time. 
Immunofluorescence Microscopy 
Mitotic HeLa cells on coverslips were treated with a microtubule stabilizing 
buffer (25 mM imidazole, pH 6.9,  10 mM KCI,  1 mM MgSO4,  l0 mM 
EGTA, 20% glycerol) containing 0.5% Triton X-100 and fixed with cold 
methanol for 10 re.in, followed by washing with TBS.  HeLa cells were 
stained with monoclonal anti-ojclin Bl (clone 2HI-H6; Oncogene Science, 
Inc., Manhasset, NY) or anti-human cyclin B anti-serum (2,000-fold dilu- 
tion, a generous gift from Dr. J. Pines, Pines and Hunter, 1991),  or anti- 
bovine adrenal cortex MAP4 (500-fold dilution, Murofushi et ai.,  1987), 
followed with secondary FITC-conjugated anti-mouse or rabbit IgG (Cap- 
pel Labs., Cochranville, PA). DNA was stained with 0.1/~g/rnl DAPI. Spec- 
imens  were  observed under an  epifluorescence microscope (Olympus, 
Tokyo, Japan). 
For some experiments, a 1/100 dilution of an anti-HeLa MAP4 antibody 
previously described (Chapin and Bulinski, 1991) and undiluted hybridoma 
supernatants of anti-cyclin B  monoclonal antibodies (GNSI,  GNS7,  and 
GNSI 1, generous gifts of Dr.  Steven Schiff, Rockefeller University, NY) 
were used to stain African green monkey kidney cells (TC-7  line) fixed 
directly in methanol. Staining protocols were described previously (Chapin 
and Bulinski,  1991). 
Western Blotting and Protein Determination 
SDS-PAGE was performed according to Laemmli (1970) with 12.5%  poly- 
acrylamide gel for p34  ode2 kinase and cyclin B, and with 5-15% polyacryl- 
amide gradient gel for MAP4. Following electropboresis, the proteins were 
transferred to nitrocellulose membrane or lrnmobilon (Millipore Corp., 
Bedford, MA) by the method of Towbin et al. (1979).  The blot was probed 
with anti-human p34  ~2  carboxy-terminal peptide (a generous gift from 
Dr. E  Matsumura,  Rutgers University, New Brunswick, NJ), anti-cyclin 
B1  (Oncogene Science, Inc.) and anti-bovine adrenal cortex MAP4 anti- 
bodies, and developed using an alkaline phosphatase-conjugated secondary 
antibody and a BCIP/NBT phosphate substrate system (KPL). 
Protein concentration was determined by bicinchoninic acid protein as- 
say reagent (Pierce Chem. Co., Rockford, IL), using bovine serum albumin 
as a standard. 
Results 
Colocalization and Copartitioning of Cyclin B with 
MAP4 in Primate Cultured Cells 
p34~cVcyclin  B  associated  with  microtubules  in  a  MAP- 
dependent manner in starfish oocytes (Ookata et al., 1993). 
To identify the MAP responsible for the binding, we chose 
primate tissue culture cells  whose major MAP  is MAP4. 
First, mitotic HeLa cells were stained with anti-cyclin B and 
compared with those stained with anti-MAP4 (Fig.  1). Both 
cyclin B (Fig.  1 A) and MAP4 (Fig.  1 C) were concentrated 
in  mitotic  spindles  as  reported  previously  (Bulinsld  and 
Borisy,  1980b;  Murofushi et al.,  1987;  Pines and  Hunter, 
1991). 
To  examine  further  the  colocalization  of cyclin  B  and 
MAP4 at various stages of the cell cycle, we used standard 
double-labeling of African green monkey cells (TC-7)  with 
anti-cyclin B and anti-MAP4 antibodies. MAP4 immunoflu- 
orescence was colocalized with microtubules irrespective of 
the cell cycle, while cyclin B, whose cellular concentration 
increased during the cell cycle, appeared with varying inten- 
sity along the microtubules of interphase cells (Fig. 2 A, a, 
b,  e,  and f).  As  reported previously  (Pines  and  Hunter, 
1991),  at the G2/M border, most of the cyclin B was translo- 
cated to the nucleus (Fig. 2 A, b). In contrast, MAP4 was 
colocalized with microtubules at this stage, and remained in 
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HeLa  cells.  HeLa  cells  were  extracted  with  a  microtubule- 
stabilizing buffer containing 0.5% Triton X-100 and 20% glycerol, 
fixed with cold methanol, and stained with anti-human cyclin B 
(Oncogene Science, Inc.) (A), anti-bovine MAP4 (C), and non- 
immune rabbit antiserum (D). Cyclin B was concentrated in the mi- 
totic spindle as was MAP4. (B) DAPI staining of HeLa cell shown 
in (A). Bar, 10 #m. 
the cytoplasm (Fig. 2 A, f). After cyclin B's transient foray 
into the nucleus, cyclin B was found associated with mitotic 
spindle fibers following nuclear envelope breakdown (Fig. 2 
A, c); MAP4 was also present on spindle fibers (Fig. 2 A, 
g). At the onset of anaphase, as previously reported, cyclin 
B was degraded, while MAP4 remained codistributed with 
microtubules, as before (Fig. 2 A, d  and h). 
To ascertain the colocalization of MAP4 and cyclin B, we 
tried two treatments of cells in which MAP4 shows unusual 
behavior  relative  to  tubulin  or  other  MAPs,  and  asked 
whether cyclin B copartitioned with MAP4. The first type 
of experiment consisted of treating cells with a low concen- 
tration  of nocodazole  (0.13  #M  for 30  min)  in  order to 
depolymerize a portion of the cellular microtubules. Under 
these conditions, because of the tubulin monomer released 
from depolymerizing microtubules, the tubulin immunofluo- 
rescence pattern was bright and diffuse, and the remaining 
microtubules were obscured (Fig. 2 B, a and c). In contrast, 
both MAP4 (Fig.  2 B, b) and cyclin B (Fig.  2 B, d) were 
mostly localized to the microtubules remaining after drug 
treatment. Second, we extracted cells with a nonionic deter- 
gent, saponin, in the absence of  glycerol, before fixation. Al- 
though the microtubules withstood the detergent extraction 
(Fig. 2 C, a and c), both MAP4 and cyclin B were solubilized 
by the extraction (Fig. 2 C, b and d) and only the faint stain- 
ing of cyclin B was observed after extraction (Fig. 2 C, d). 
In contrast to MAP4,  125-kD MAP (ensconsin)  is resistant 
to the detergent extraction and remains associated with mi- 
crotubules in detergent-treated cells (Bulinski and Bossier, 
1994). These correlative results are consistent with the par- 
ticipation of MAP4 in the binding of cyclin B, presumably 
as a complex of p34~cVcyclin B, to microtubules in vivo. 
Cosedimentation of  p34c*2/cyclin  B Complex with 
Microtubules in HeLa Cell Extracts 
To examine the association of p34cdcVcyclin  B complex with 
microtubules  in  HeLa  cells  biochemically,  we  prepared 
taxol-polymerized microtubules  from mitotic  HeLa cells 
and immunoblotted these with anti-human p34  cdc2 and anti- 
cyclin B antibodies as we had clone previously with starfish 
oocytes (Ookata  et  al.,  1993).  Protein  staining  of HeLa 
microtubule proteins is shown in Fig.  3 A, lane 1.  Tubulin 
(indicated by q'u) was a major protein in the fraction. A band 
that was visible at ,o200 kD by CBB staining probably corre- 
sponds to MAP4 as suggested by blotting with anti-MAP4 
(labeled MAP4  in Fig.  3 A,  lane 2).  p34  c~2 and cyclin B 
proteins present in the microtubule preparations are shown 
by blotting with anti-human p34  ~c2 (Fig.  3 A, lane 3) and 
anti-cyclin B~ antibodies (Fig.  3 A, lane 4).  Almost all of 
the  p34c~2/cyclin  B  complex  in  the  HeLa  cell  extracts 
sedimented with microtubules (although a portion of cyclin 
B in HeLa cells sedimented with membrane particles by cen- 
trifugation  of the  homogenate),  and  this  p34~2/cyclin  B 
complex was released from microtubules by a high salt solu- 
tion together with MAP4 (data not shown). 
Since the  active form of p34cd,Vcyclin B  complex pos- 
sesses  high  histone  HI  kinase  activity,  we examined the 
histone  H1  kinase  activity  of the  microtubule-associated 
p34~2/cyclin B  complex. When histone H1  was  added to 
the microtubule fraction as an exogenous substrate, heavy 
phosphorylation of histone H1 was detected (Fig. 3 B, lane 
1).  This histone HI phosphorylation was not inhibited by 
cAMP-dependent protein kinase inhibitor (Fig. 3 B, lane 2), 
eliminating the contribution of cAMP-dependent protein ki- 
nase.  Since Ca  2÷  was  depleted by  EGTA in  the  reaction 
mixture, contribution of protein kinase C and Ca2+/calmod - 
ulin-dependent protein kinase was not expected. These re- 
suits suggest this historic H1 kinase activity is mostly due to 
p34  c~c2 kinase associated with microtubules. 
Possible endogenous substrates for this kinase were exam- 
ined by phosphorylation of the crude microtubule pellet in 
the absence of any exogenous substrates. Two major distinct 
phosphorylated bands were detected (Fig. 3 B, lane 3). The 
broad higher molecular mass band was shown to be com- 
posed of at least two proteins: a heat stable 200-kD protein 
and a little larger heat labile protein (Fig. 3 C, lanes 3 and 
4). We identified the heat stable 200-kD protein as MAP4 
because  of  its  electrophoretic  mobility,  anti-MAP4  im- 
munoreactivity, as well as, of course, its heat-stability (Fig. 
3  C,  lanes  1  and  3).  The  identities  of the  other  phos- 
phorylated species are less  certain.  The heat labile phos- 
phoprotein could be a myosin heavy chain or a 210-kD heat- 
labile microtubule-interacting protein reported recently by 
Draberova and  Draber  (1993).  The lower phosphorylated 
protein,  migrating  at around  120 kD,  may correspond to 
125-kD MAP,  which was recently purified and named en- 
sconsin  (Bulinski and Bossier,  1994). 
Phosphorylation of the 200-kD species was not inhibited 
by cAMP-dependent protein kinase inhibitor (Fig. 3 B, lane 
4) but was abolished by the addition of. Histone H1 (see Fig. 
3 B, lanes 1  and 2),  suggesting that contribution of MAP 
The Journal of Cell Biology, Volume  128, 1995  852 Figure 2.  Colocalization and copartitioning of cyclin B with MAP4 in African green monkey kidney cell  (TC-7).  (A) Colocalization of 
cyclin B (a-d) and MAP4 (e-h) at several stages of cell cycle. TC-7 cells were methanol-fixed  and double stained  with monoclonal anti- 
cyclin B (a generous girl from Steven Schiff, Rockefeller University, NY) and polyclonal anti-human MAP4. The cell cycle stages depicted 
in the micrographs are interphase  (a and e), G2/M transition (b and f), metaphase (c and g), and telophase (d and h).  (B) Association 
of cyclin B and MAP4 with subsets of microtubules remaining after partial  depolymerization with 0.1/~M nocodazole for 30 rain.  Double 
staining with anti-mbulin  (a) and anti-MAP4 (b). Double-staining of methanol  fixed ceils with anti-tubulin  (c) and anti-cyclin B (d). Note 
that the tubulin staining  appeared bright and diffuse because of depolymerized, monomeric tubulin,  while both MAP4 and cyclin B were 
associated  with the remaining microtubule polymers. (C) Coextraction of MAP4 and cyclin B from the microtubule cytoskeleton by deter- 
gent treatment.  TC-7 cells were extracted with the detergent,  saponin (0.2 mg/ml) in PEM buffer (without glycerol) for 2 min before metha- 
nol fixation.  Double staining  with anti-tubulin  (a) and anti-MAP4 (b).  Double staining  with anti-tubulin  (c) and anti-cyclin B (d). Note 
that, as previously reported (Schliwa et al.,  1981; Bulinski and Bossier,  1994), MAP4 was extracted  from microtubules  during detergent 
extraction.  Cyclin B showed the same behavior as MAP4 upon extraction.  Bar,  10 #m. 
Ookata et al. Association and Phosphorylation of MAP4 with p34  ~ac2 Kinase  853 Figure 3. Detection of p34~Vcyclin  B and MAP4 in the microtubule fraction prepared  from mitotic HeLa cells.  HeLa cells were syn- 
chronized at S-phase by thymidine block and then at M-phase by nocodazole treatment.  Microtubules were polymerized with the aid of 
taxol in the mitotic HeLa call extract and precipitated through 10 % sucrose cushion by centrifugation. (.4) Immunoblotting of  microtubule- 
proteins with anti-MAP4, anti-human p34  ~2 and anti-cyclin B~ antibodies. Lane 1, CBB staining of microtubule-proteins; lane 2, blotting 
with anti-MAP4; lane 3, blotting with anti-human p34  ~dc2 antibody; lane 4, anti-cyclin B~. (B) Autoradiograph showing phosphorylation 
of excess histone H1 and endogenous proteins by microtubule-associated kinase. Phosphorylation of historic H1 by microtubule-associated 
kinase  in the absence  (lane  1)  and presence  (lane 2)  of protein  kinase  A  inhibitor,  and phosphorylation  of endogenous proteins  by 
microtubule-associated kinase in the absence (lane 3) and presence (lane 4) of protein kinase A inhibitor. Note that phosphorylation  of 
200-kD bands was inhibited in the presence of  historic HI 0anes I and 2). Inhibition of  phosphorylation was also observed when 0.5 mg/mi 
p34  ~d~2 kinase peptide  (CKASPEKAKSPVKE)  was added  to the  reaction  mixture  (lane 5).  (C) Identification of a heat-stable  phos- 
phorylated 200-kD species as MAP4. HeLa microtubule proteins were incubated in the presence of [3,-32P]ATP at 30°C for 20 min. The 
phosphorylation  reaction was stopped by boiling for 5 min in the presence of 0.5 M NaCI. The heat-stable supernatant  (lanes 1 and 3) 
and -labile precipitate fractions 0anes 2 and 4) were autoradiographed (lanes 3 and 4) and immunoblotted with anti-MAP4 antibody (lanes 
1 and 2) after 7.5% SDS-PAGE. (D) The effect of immunodepletion of p34~2/cyclin B kinase on MAP4 phosphorylation,  p34~2/cyclin 
B kinase was removed from the 0.5 M NaCl-extracted MAP4 fraction by immunoprecipitation with anti-human cyclin B. The supernatant 
fractions were incubated to allow for phosphorylation of  exogenously added MAP4 (lane 2). The control experiment, in which the precipita- 
tion was carried out without first antibody is shown in lane 1. MAP4, tubulin,  cyclin B, p34  "d:2 and histone H1 are indicated by MAP4, 
Tu, cyc B, cdc2,  and H1, respectively. 
kinase  in  MAP4  phosphorylation,  if present,  was minor. 
Synthetic peptide containing the Ser-Pro-Glu(Val)-Lys [SPE- 
(V)K] amino acid sequence,  which represents a  consensus 
sequence for phosphorylation by p34  ¢~2 kinase (Hisanaga et 
al.,  1991)  abolished phosphorylation of MAP4  (Fig.  3  B, 
lane  5)  as  did  a  p34  ~2  kinase  inhibitor,  butyrolactone  I 
(Kitagawa et al., 1993) (data not shown). Whether MAP4 ki- 
nase in the microtubule fractions is due to p34~2/cyclin B 
kinase was further confirmed by its immunodepletion from 
the MAP fraction with an anti-cyclin B antibody. To detect 
the kinase activity distinctly, HeLa MAP4 prepared from in- 
terphase cells was added as a substrate to the reaction mix- 
ture. Immunodepletion decreased MAP4 phosphorylation to 
about 10% of the control (Fig. 3 D). These results indicate 
that p34  ~2 kinase associated with microtubules is capable 
of phosphorylating MAP4, which is apparently a detectable 
p34  c~2 kinase substrate, among HeLa microtubule proteins. 
p34c~Z/cyclin B Binds to Microtubules through the 
Interaction of  MAP4 and Cyclin B 
To determine  whether  the  binding  of the  p34~dc2/cyclin B 
complex to  microtubules results  from binding  directly to 
tubulin  or to MAP4,  the cosedimentation experiment was 
repeated  using  purified  proteins.  MAP4,  tubulin,  and 
p34~cVcyclin  B  were  purified  from  HeLa  cells,  porcine 
brain  and  starfish  oocytes,  respectively,  as  described  in 
Materials  and  Methods  (Fig.  4  A,  top). The  binding  to 
microtubules was detected  by Western  blotting with  anti- 
cyclin B or anti-p34  ~'~2 antibody, p34"kVcyclin B  alone did 
not  sediment  when  centrifuged  in  the  presence  of 0.1% 
Nonidet P-40  (Fig.  4  A,  lanes  1  and 2).  A  small portion 
(18%) of p34~Vcyclin B  was detected in the microtubules 
sedimented in the absence of MAPs (Fig. 4 A, lanes 3 and 
4),  while  70%  of the  complex  added  sedimented  with 
microtubules in the presence of purified MAP4 (Fig.  4 A, 
lanes 5 and 6) when estimated with the amount of cyclin B. 
This result indicates  that the p34cd~Vcyclin B  complex as- 
sociates with microtubules in vitro by virtue of its binding 
to MAP4. 
Association  of  p34~c2/cyclin  B  complex  with  MAP4 
could be brought about by binding of either p34  cdc2 or cyclin 
B to the MAP4. Accordingly, we tested the ability of cyclin 
B  to  bind  to  MAP4.  We prepared  GST-starfish cyclin  B 
beads  and,  as  controls,  glutathione-Sepharose  beads  and 
GST-Xenopus cyclin D  beads (K.  Tachibana and T.  Kishi- 
moto, unpublished observation), and tested which of these 
was capable of binding to MAP4. MAP4 was bound to GST- 
cyclin B beads (Fig. 4 B, lane 4) but was not bound to either 
of the control beads (Fig. 4 B, lanes 2 and 6). These results 
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p34¢dc2/cyclin  B complex with 
microtubules  is  mediated 
by  the  interaction  between 
MAP4 and cyclin B proteins. 
(A) In vitro cosedimentation 
of p34cdc2/cyclin B  with  mi- 
crotubules  in  the  presence 
and absence of MAP4. Upper 
gels  represent  purified  pro- 
teins used for the cosedimen- 
tation  experiment.  MAP4, 
tubulin  (Tub) and  p34c~Vcy  - 
clin  B  (MPF)  were  purified 
from mitotic HeLa cells,  por- 
cine  brains  and  starfish  oo- 
cytes,  respectively,  as  de- 
scribed  in  Materials  and 
Methods.  p34c*2/cyclin B was 
incubated  with  microtubules 
polymerized  from  porcine 
brain  tubulin  in  the  absence 
(lanes 3 and 4) and presence 
of HeLa MAP4 (lanes  5  and 
6).  After centrifugation,  the 
supernatants  (S;  lanes  3  and 
5) and pellets  (P; lanes 4 and 
6)  were  analyzed  by  immunoblotting  with  anti-cyclin  B. 
p34~Vcyclin B alone treated in a similar  way is shown in lanes 1 
(S) and 2 (P).  (B) Immunoblot demonstrating the association of 
MAP4  with  cyclin B  protein.  GST-starfish  cyclin B  and  GST- 
Xenopus cyclin D fusion protein were expressed in E. coli and cou- 
pled  with  glutathione-beads  as  described  in  Materials  and 
Methods.  MAP4 was incubated with glntathione-beads  (lanes 1 and 
2),  GST-cyclin B-beads  (lanes  3 and 4) and GST-cyclin D-beads 
(lanes 5 and 6). After centrifugation,  the supernatants  (lanes 1, 3, 
and 5) and the pellets (lanes 2, 4, and 6) were analyzed by immuno- 
blot with anti-MAP4 antibody.  MAP4 bound only to GST-cyclin 
B-beads  (lane 4) but not to glutathione-  or cyclin D-beads (lanes 
2 and 6). 
demonstrate that cyclin B  is capable of binding to MAP4, 
thus bringing about association of the p34c~c2/cyclin B com- 
plex with microtubules  in vitro. 
Cyclin B Associates with the Proline-rich Region 
of the MAP4 Molecule 
MAP4 is a large protein possessing multiple functional do- 
mains (Fig. 5 A). We tested which of these MAP4 domains 
is  capable  of  p34°dc2/cyclin  B  complex  binding.  Various 
fragments of MAP4 were produced in E. coli using a bovine 
MAP4 eDNA  (Aizawa et  a.,  1991a).  When GST-cyclin B 
beads  were  incubated  with  the  amino-terminal  half (NR, 
amino acid residues 11-533, corresponding to the projection 
domain)  or  the  carboxy-terminal  half  (PA~,  amino  acid 
residues  534-1072,  corresponding  to  the  microtubule- 
binding domain)  (Fig.  5  A)  and then precipitated  by brief 
centrifugation,  only  PA4  was  detected  in  the  precipitated 
GST-cyclin B beads (Fig. 5 B, lanes 3, 4, 9, and 10). When 
NR or PA4 was  incubated  with  glutathione-Sepharose  4B 
beads or GST-cyclin D beads, no binding of MAP4 domains 
was  detected  with  either  of these  control beads  (Fig.  5B, 
lanes 1, 2, 5-8,//,  and 12), demonstrating the specificity of 
binding of PA4 to cyclin B  beads. 
Figure 5.  The domain structure of bovine MAP4 and association 
of cyclin B with the Pro-rich region of MAP4.  (A) The domain 
structure of bovine MAP4 and fragments used in the binding ex- 
periments.  The NH2-terminal  half and the COOH-terminal half 
are represented  by NR and PA4, respectively.  The Pro-rich region 
(P)  located  in  the  NHE-terminal  half of PA4 is  indicated  as  a 
shaded area.  The A4 fragment (A4) consists  of four imperfectly 
repeated  sequences  within  the assembly promoting (AP) region, 
which is indicated  by black and white stripes,  as well as a tail re- 
gion. These MAP4 fragments  were expressed  in E. coli, using bo- 
vine MAP4 eDNA (Aizawa et al.,  1991a). (B) NR (lanes I  to 6) 
and PA4 (lanes  7-12) of MAP4 were incubated  with  glutathione- 
beads (lanes 1, 2, 7, and 8), GST-cyclin B-beads (lanes 3, 4, 9, and 
10) and GST-cyclin D-beads (lanes 5, 6, 11, and 12), respectlvely. 
After brief centrifugation,  the supernatants  (S) and the pellets (P) 
were anatyzed by immunoblot with anti-MAP4. (C) P (lanes I and 
2) and A4 (lanes  3 and 4)  fragments  were incubated  with GST- 
cyclin B-beads,  and after centrifugation  the supernatants  (lanes  1 
and 3) and the pellets (lanes 2 and 4) were analyzed by immunoblot 
with anti-MAP4. (D) The binding of PA4 to GST-cyclin B beads as 
a function of GST-cyclin B bead concentration. 5/zg/ml PA4 was 
incubated  for 20  min at  4°C  with  GST-cyclin  B  beads  diluted 
8- (lanes 2 and 6), 4- (lanes 3 and 7), or undiluted bead preparation 
(lanes 4 and 8), respectively, with control Sepharose CL-4B beads. 
Control Sepharose  CL-4B beads alone are shown in lanes I  and 5. 
After washing with 20 mM Pipes,  pH 6.8, 1 mM MgSO4,  1 mM 
EGTA, 0.1 M NaCI, and 0.1% Nonidet P-40, PA4 in the unbound 
fractions (supernatants;  lanes  1-4) and GST-cyclin B beads in the 
bound fractions (pellets;  lanes 5-8) was analyzed by immunoblot- 
ting with anti-bovine MAP4. Salt (0.35 M NaCI) extraction of GST- 
cyclin B beads-PA4  complex,  followed  by centrifugation  of the 
beads,  dissociated  PA4 from cyclin B beads,  as was shown in lane 
9 (extracted  supernatant  fraction)  and  lane 10 (precipitated  bead 
fraction). 
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with cyclin B, two subfragments of PA4, the amino-terminal 
half  of  PA4  (P,  amino  acid  residues  647-865)  and  the 
carboxy-terminal  half  of  PA4  (A4, amino  acid  residues 
870-1072)  (Fig.  5 A),  were prepared and their binding to 
GST-cyclin B beads was examined. The P  fragment corre- 
sponds to the positively charged MAP4 region enriched in 
Pro residues  (Pro-rich  region),  and the  A4 fragment con- 
sists of four imperfect repeat sequences  (AP-sequence re- 
gion) that contribute to the assembly-promoting ability of 
MAP4 (Aizawa et al.,  1991a) and a hydrophobic tail region. 
When GST-cyclin B beads were incubated with each of these 
fragments, only the P fragment was detected in the fraction 
bound to the GST-cyclin B beads (Fig. 5 C, lane 2), indicat- 
ing that the Pro-rich region is the  fragment of the  MAP4 
molecule sufficient to mediate cyclin B  association. 
The binding of PA4 to GST-cyclin B beads was studied by 
varying the concentration of GST-cyclin B beads (Fig. 5 D, 
lanes 1-8). The concentration of GST-cyclin B beads was ad- 
justed by dilution with control Sepharose beads. The amount 
of P,M bound to beads increased according to the amount of 
GST-cyclin B  beads.  When  undiluted  GST-cyclin B  beads 
were used,  most of PA~ (5/~g/ml) bound to the beads and 
PA, was not  detected  in  the  supernatant  fraction (lanes  4 
and  8).  To  determine  whether  PA4-cyclin  B  binding  is 
ionic,  we  treated a  PA4-cyclin  B  bead pellet with 0.35  M 
NaC1. Following a centrifugation step, PA4 was found only 
in the supernatant fraction,  indicating that it had been dis- 
sociated from cyclin B by salt treatment (Fig.  5 D, lanes 9 
and 10). 
p34  ~.2 Kinase Phosphorylates MAP# In Vitro 
Observation of a physical association of p34  ~d'2 kinase with 
MAP4 suggested to us that intracomplex phosphorylation of 
MAP4 might occur within the ternary complex consisting of 
p34~dcVcyclin B/MAP4.  To  test  this  possibility,  we  per- 
formed  phosphorylation  of the  PA4  fragment  of  MAP4, 
which had been bound to the p34~¢2/cyclin  B  complex im- 
mobilized on p13 ~  beads.  The p34c~cVcyclin B/PA4 com- 
plex  adsorbed  to  p13 ~¢~  beads  was  incubated  with  [~- 
32p]ATE  subjected  to  SDS-PAGE,  and  autoradiographed. 
Fig. 6 shows that a labeled band comigrated with PA4 (lanes 
Figure 6. Intracomplex phos- 
phorylation  of PA4 by p34  ~d~2 
kinase  in  the  PAdp34cdc2/ 
cyclin  B  complex.  Purified 
starfish  p34  ~d~2  kinase  was 
bound to p13  s~t Sepharose 4B 
by incubating  for 30  min at 
0°C.  After  washing, p34  ~d¢2 
kinase-pl3 ~t  Sepharose  was 
further  incubated  with  the 
PA~ fragment of MAP4 for 30 
min  at  0°C.  After  washing, 
PA~  retained  on  beads  was 
phosphorylated by incubating 
with  [)'-32p]ATP.  Lane  1, 
CBB staining  of PA4 protein  to indicate  the position  of PA4 on 
SDS-PAGE; lane 2, phosphorylation  of PA4 bound to p34~d¢2/cy  - 
clin B-pl3  ~m beads; lane 3, an autoradiograph  from a control ex- 
periment in which PA4 was incubated with p13  ~t beads before the 
binding of p34~dC2/cyclin B to the beads. 
1 and 2), while no phosphorylation was detected in a control 
experiment in which  PA4 was incubated with p13 suc~ beads 
before application of p34cdcVcyclin B  (lane 3). 
The  stoichiometry of phosphorylation was measured by 
incubating  heat  stable HeLa MAP4  with purified  starfish 
p34  cdc2 kinase. Approximately eight moles of phosphate was 
incorporated per mole of MAP4 (Fig. 7 A). This value is in 
approximate agreement with the number of (S/T)PX(R/K) 
p34  ~d°2 kinase consensus sequences (six sites) found in hu- 
man MAP4 (Chapin and Bulinski,  1991; West et al.,  1991). 
Furthermore, we observed 3 mol of phosphate incorporated 
into bovine adrenal cortex MAP4  (data not shown)  which 
contains  four consensus  sequences  (Aizawa et al.,  1990). 
These results suggest that under our reaction conditions most 
sequences that resemble the (S/T)PX(R/K) consensus within 
MAP4  are  capable  of phosphorylation  by  p34  c~c2 kinase. 
Fig. 7 B, lanes 1 and 2 represent the protein staining of un- 
phosphorylated (lane I ) and phosphorylated MAP4 (lane 2). 
Comparison of lanes I  and 2 shows that phosphorylation by 
p34  c~c2 kinase  decreased  the  electrophoretic  mobility  of 
MAP4 as previously observed by Vandre et al.  (1991). 
Phosphorylation of  MAP4 by p34  ~dc2 Kinase: Effect on 
Microtubule Dynamics 
Since MAP4 is capable of binding to and undergoing phos- 
phorylation by the  p34°d~Vcyclin B  kinase,  we determined 
the effects that this phosphorylation might have on MAP4's 
ability to bind to and stabilize microtubules.  Unphosphor- 
ylated MAP4, and MAP4 phosphorylated by p34  cd~2 kinase, 
were incubated  with taxol-stabilized microtubules and the 
mixtures were centrifuged. Both forms of MAP4 were recov- 
ered exclusively in the sedimented microtubules (Fig.  7 B, 
A 
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Figure 7.  Phosphorylation  of MAP4 by p34  cdc2 kinase.  (A) Time 
course of phosphorylation  of HeLa MAP4 by purified p34  cdc2 ki- 
nase. HeLa MAP4 was incubated with starfish oocyte p34  cdcz ki- 
nase at 30°C. The amount of label incorporated into MAP4 was ex- 
pressed  in mol Pi/mol  protein,  assuming the molecular  mass of 
MAP4 to be 110 kD (Aizawa et al.,  1990). Lanes 1 and 2 in (B) 
represent  SDS-PAGE of unphosphorylated  (lane  1)  and  phos- 
phorylated MAP4 (lane 2), demonstrating that phosphorylation de- 
creased the electrophoretic mobility of MAP4. (B) Sedimentation 
of phosphorylated  MAP4  with  microtubules.  Unphosphorylated 
(lanes 3 and 4) and phosphorylated HeLa MAP4 (lanes 5 and 6) 
were incubated with microtubules polymerized from porcine brain 
tubulin with taxol. The mixtures were centrifuged to sediment mi- 
crotubules, and their supernatants (lanes 3 and 5) and pellets (lanes 
4 and 6) were subjected to SDS-PAGE. HeLa MAP4 and tubulin 
are indicated by MAP4 and Tu, respectively. 
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was still competent to bind to microtubules. 
To determine if phosphorylation of MAP4 by p34  cdc2 ki- 
nase might play a role in modulating microtubule dynamics, 
we analyzed the changes in length of individual microtubules 
by  dark-field  microscopy.  Under  conditions  described  in 
Materials and Methods, microtubules in the absence of MAP 
were quite labile, and most microtubules disappeared with- 
out rescue (the phase transition  from depolymerization to 
polymerization) after catastrophe (the phase transition from 
polymerization to depolymerization)  (Fig.  8  B,  a)  as has 
been reported by Walker et al.  (1989). 
The effects of MAP4 and its phosphorylation on microtu- 
bule stabilization are represented as whole CRT (cathode- 
ray tube) views of the typical image in Fig. 8 A. There were 
many microtubules at 3 min after addition of MAP4 in either 
specimens of unphosphorylated (25 #g/ml) (Fig. 8 A, a) or 
phosphorylated  MAP4  (25  /xg/ml)  (Fig.  8  A,  c).  Micro- 
graphs of the same field, 16 min after addition of MAP4, are 
shown in Fig. 8 A, b and d. In contrast to MAP-free microtu- 
bules, all of which disassembled in a few minutes (data not 
shown), a considerable number of microtubules remained in 
the presence of unphosphorylated MAP4 (Fig. 8 A, b), indi- 
cating that MAP4 possesses the ability to stabilize microtu- 
bules. On the other hand, when phosphorylated MAP4 was 
added, the number of microtubules remaining after 16 min 
was reduced  greatly  (Fig.  8  A,  d),  suggesting that  phos- 
phorylation  by  p34  c~2  kinase  had  reduced  the  ability  of 
MAP4 to stabilize microtubules. 
Dynamics  of individual  microtubules  was  analyzed  by 
monitoring the change in microtubule length from the im- 
ages recorded on videotapes as described in Materials and 
Methods. Typical examples of the dynamics of single micro- 
tubules are shown in Fig. 8 B. A plus end was distinguished 
from a minus end by its more dynamic behavior. In the ab- 
sence of MAP4,  once depolymerization began at the plus 
end, the microtubule disappeared immediately without res- 
cue (Fig. 8 B, a). In the presence of unphosphorylated MAP4 
(50 #g/ml), microtubules became very stable and almost no 
changes were observed in the microtubule length (data not 
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Figure  8.  Effect  of  MAP4 
phosphorylation  by  p34  ¢dc2 
kinase  on  microtubule  dy- 
namics. (A) Dark field micro- 
graphs  showing the  effect of 
phosphorylation  with  p34  c'~2 
kinase  on  microtubule-stabi- 
lizing ability of MAP4. Tubu- 
lin  solution  (3.7 mg/ml)  was 
incubated for five minutes at 
37°C to allow the spontaneous 
formation of microtubules. Un- 
phosphorylated  (a and  b)  or 
phosphorylated  MAP4 (c and 
d) was then added to the tubu- 
lin solution. Final tubulin and 
MAP4  concentrations  were 
~1.8 mg/ml and 25/zg/ml,  re- 
spectively. 5 #1 of each solu- 
tion  was  immediately  trans- 
ferred  to  a  glass  slide,  and 
observed  with  a  microscope 
under dark field illumination. 
a and c are micrographs taken 
3  min,  while  b  and  d  were 
taken  16 min,  after addition 
of  MAP4.  Bar  represents 
10 /~m. (B) Length histories 
of  representative,  individual 
microtubules  in  the  pres- 
ence of unphosphorylated and 
phosphorylated  MAP4.  (See 
Table I for information on the 
population  of microtubules.) 
Changes  in  microtubule 
length  were  tracked  at  both 
the plus and minus ends of a 
single microtubule in the absence (a), and the presence of unphosphorylated (b, 13 #g/ml) and phosphorylated (c, 30/zg/ml) MAP4. Filled 
and open  circles  indicate the plus and  minus end of the microtubules,  respectively. Phosphorylation  by p34  ~c2 kinase decreased  the 
microtubule-stabilizing  ability of MAP4; the microtubule's behavior in the presence of phosphorylated MAP4 is apparently similar to the 
behavior of a microtubule in the absence of MAP4. To show more dynamic behavior at the plus end of microtubules, results from a low 
concentration  (13/zg/ml) of unphosphorylated MAP4 were selected for presentation  in (b); even in the presence of a high concentration 
(30/,g/ml) of phosphorylated MAP4 (c) MAP4 showed almost no microtubule stabilizing capacity. Catastrophe and rescue events are indi- 
cated by arrows pointed downward and upward, respectively. 
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tion of shortening appeared to increase, resulting in quite 
frequent conversions between elongation phases and short- 
ening phases at the plus end as shown in Fig. 8 B, b (13 #g/ml 
unphosphorylated MAP4). From the profile of microtubule 
length, it could be speculated that microtubule-stabilization 
by MAP4 is due to enhanced rescue events at the plus end. 
When phosphorylated MAP4 was  added,  the rescue fre- 
quency decreased remarkably.  Even in the presence of a 
higher concentration of phosphoryhted MAP4 (30/~g/ml in 
Fig.  8 B, c), microtubules were very unstable and only a 
few rescue events were observed before the microtubules de- 
polymerized completely. 
To determine the detailed effect of phosphorylated MAP4 
on  microtubule  dynamics,  experiments  in  which  varied 
MAP4 concentrations were used would be optimal. How- 
ever,  because 30  #g/ml was the highest concentration of 
phosphorylated MAP4  we could prepare,  we limited our 
comparison of various parameters of microtubule dynamics 
to lower MAP4 concentrations. Accordingly, we compared 
dynamics in the presence  of 26  ttg/ml unphosphorylated 
MAP4 and 30 #g/ml phosphorylated MAP4 (Table I). The 
most notable change produced by addition of MAP4, or by 
its phosphorylation, was the frequency of rescue. Because 
the  frequency of rescue  at  the  plus  end  was  quite  low 
(0.004/s)  in the absence of MAP4, most microtubules disap- 
peared without any rescue.  Addition of unphosphorylated 
MAP4 increased the rescue frequency more than 30-fold 
(0.128/s). When phosphorylated MAP4 was added instead of 
unphosphorylated MAP4, the frequency of rescue decreased 
almost five-fold,  to 0.027/s.  In contrast,  the frequency of 
catastrophe was similar in the presence of phosphorylated 
MAP4 (0.008/s)  and in the presence of unphosphorylated 
MAP4 (0.01/s). These results support our previous assertion 
that MAP4 increases the frequency of rescue while its phos- 
phorylation by p34  c~2 kinase reduces its rescue frequency 
significantly. 
In  order  to  perform  many  experiments  with  limited 
amounts of material, we used two types of MAP4 prepara- 
tion.  We performed this experiment eight times with six 
different preparations  of MAP4;  two times with purified 
MAP4 and six times with crude MAP4 preparations. With 
all MAP4 preparations, the effect of phosphorylation that we 
observed was the same, that is, phosphorylation decreased 
the microtubule-stabilizing ability of MAP4. Data presented 
in Fig. 8 and in Table I were obtained from experiments with 
these crude MAP4 preparations. Although there were sev- 
eral contaminating proteins in the crude MAP4 fractions, 
MAP4 was the only microtubule binding protein present, 
i.e., the only protein that bound to taxol-stabilized microtu- 
bules (data not shown; also see Fig. 4, Chapin and Bulinski, 
1994). Although the potency of microtubule-stabilizing abil- 
ity varied somewhat among MAP4 preparations, our data 
suggested that this difference may represent differences in the 
fraction of active MAP4 within each preparation. 
Discussion 
p34  ~2 Kinase Is Targeted to Microtubules at Mitosis 
We have  shown here  in primate  tissue culture cells that 
the p34~cVcyclin B complex associates with microtuhules 
through the binding between cyclin B and MAP4. Consider- 
ing that the microtubule cytoskeleton is one of the major tar- 
gets of p34  '~c2 kinase at mitosis,  this binding could be a 
possible mechanism for p34  cdc2 kinase to perform its action 
on the microtubule cytoskeleton efficiently. 
In our work, we have demonstrated that cyclin B binds to 
the Pro-rich region of the MAP4 molecule. Although the 
MAP4 fragments used in this experiment were synthesized 
in E. coli from bovine MAP4 cDNA instead of from human 
(HeLa) MAP4 cDNA, the same result would be expected 
with HeLa MAP4, because bovine MAP4 has been shown 
to have an amino acid sequence very similar to that of  human 
MAP4. For example, the identity of amino acid residues in 
the Pro-rich region is 76%  overall (Fig. 9,  Aizawa et al., 
1990;  Chapin and Bulinski, 1991), and the amino-terminal 
half of the Pro-rich region is >85 % conserved between bo- 
vine and human. This region is of special interest because 
of the high proportion of basic amino acid residues (18%) 
and the complete conservation of their positions between hu- 
man and bovine MAP4. Although the exact site within the 
Pro-rich region that interacts with cyclin B has not yet been 
determined, ionic interactions might cause their binding, as 
suggested from the fact that a moderate salt concentration 
dissociated cyclin B-MAP4 binding (Fig. 5 D and Bulinski, 
J. C., S. Hisanaga, K. Tachibana, and T. Kishimoto, unpub- 
lished results). 
Association with microtubules seems to be a unique char- 
acteristic  of p34  ¢~c2 kinase complexed with cyclin B.  No 
other  cdc2-  (or  cdk-)  complexes  involved  in  cell  cycle 
progression have been found to associate with microtubules 
Table I. Effect of  MAP4 and lts Phosphorylation  on Microtubule Dynamics 
: "  Catastrophe  Rescue  Growth*  Shortening* 
Growth rate  Shortening rate  frequency  frequency  length  length 
i~m/min  izra/min  sec-~  sec-I  ix  m  ~m 
Plus end 
MAP-free  1.31  5:0.43  10.61  5:2.88  0.006  0.004  3.5  40.40 
(n  =  22)  (n  =  22) 
Native MPA4*  0.85  5:0.39  8.94  5:3.55  0.01  0.128  1.25  0.93 
(n = 30)  (n = 29) 
Phosphorylated MAP4§  0.93 5:0.32  9.42 5:3.94  0.008  0.027  2.05  3.94 
(n =  26)  (n =  26) 
* Growth or shortening length was calculated  by dividing the total  number of transitions by the summed length of growth or shortening. 
~: 26 #g/ml unphosphorylated MAP4. 
§ 30 t~g/ml phosphorylated MAP4. 
The Journal of Cell  Biology, Volume 128,  1995  858 human  694  PP~-~TEPLATTQPAKTSTSKAKTQPTSLPKQPAPTTIGGLNKEP~SL 
mouse  665  --~---tA  ...............................  S .......... 
bovine  641  ..................................  ~  L--S  ....... 
human 744 ASGLVPAAPPILRPAVAS**ARPS[LPSKDVKPKPIADAKAPEKRA~-P~P 
mouse  715  ---S-?---H  ....  A-TAT ....  T--AR .......  TE--VA---~  ....  I" 
bovine  691  ---S  ..........  A-T**S---T  .....  T ....  V-E--I  ....  --~.~-~2-- 
human 
mouse 
bovine 
792  ASAPASRSGSKSTQTVAKTTTAAAVASTGPSSRSPSTLLPLKPTAIKTEG 
765  S ....  LKP-P-T-P--S-A-SPSTLV  .........  A-T---R--S  ..... 
739  .....  VKP ......  A-P-APAT-TL-SP-ST--~-TP---R  ........ 
human 
mouse 
bovine 
84Z KPAEVKKMTAKSVPADLSRPKSTSTSSMKKTTTLSGTAPAAGVVPSRVKA 
815  ---D--R  .....  AS .....  S-T--A--V-RN--PT-A--P-qdTST---P 
789  ....  I---AT--A  ..........  T---V--S--VP  ....  P--*A---ARP 
hllman 
mOUSe 
bovine 
892  TPMPSRPSTTPFIDKKPTSAKPSSTTPRLSRLAT~SAPDLKN  934 
865  MSA---S-GALSV  ......  T ....  SA--V .....  TV ......  S  907 
838  -AT-P---G--PV  .....  A---T-SA---G-V-A-A  .......  880 
Figure 9. Comparison of amino acid sequences of Pro-rich region 
among human, mouse and bovine MAP4. The Pro-rich region of 
human MAP4, amino acid position 694-934, is aligned with a ho- 
mologous sequence in mouse MAP4, amino acid position 665-907, 
and the corresponding region of bovine MAP4, amino acid posi- 
tions 641-880. Identical amino acids within human, mouse and bo- 
vine MAP4 are represented by a bar and deletions are indicated by 
asterisk.  Possible phosphorylation sites, which are composed of 
consensus sequences (Ser-Pro-X-Lys) for p34  ~dc2 kinase, are en- 
closed in boxes. Ser-Pro and Thr-Pro sequences, which were sug- 
gested by Aizawa et al. (1991b) to be sites for phosphorylation of 
bovine MAP4 by p34  ~c2 kinase, are indicated by a double un- 
derline. 
or to phosphorylate them, and none colocalize with microtu- 
bules in vivo. Cyclin A shows predominantly nuclear local- 
ization during S to G2 phase, although a small fraction as- 
sociates with centrosomes (Pines and Hunter, 1991).  After 
nuclear envelope breakdown, cyclin A  becomes dispersed 
throughout the cell (Pines and Hunter, 1991) and is not de- 
tected in the isolated mitotic spindles (Tombes et al., 1991). 
Although the cellular distribution of other cyclins has not 
been studied in detail, cyclin D, which is one of the G1 cy- 
clins (for review see Hunter and Pines, 1991) is found in the 
nucleus (Xiong et al., 1992), and in our assays, cyclin D did 
not show binding to either HeLa MAP4 or any fragments of 
the bovine MAP4 molecule. Specific association of only cy- 
clin  B/p34  ~dc2 with  MAP4  and  microtubules  might  have 
been predicted, since the microtubule network changes dra- 
matically  only at  the  beginning  of M-phase  when cyclin 
B-associated p34  ~d¢2 kinase is activated, and shows no ap- 
parent response to changes in activity of interphase cdld 
cyclin complexes. 
Most of the p34~dcVcyclin  B complex translocates into the 
nucleus from the cytoplasm before nuclear envelope break- 
down and accumulates on the chromosomes, nucleolus, and 
nuclear lamina (Pines and Hunter, 1991; Bailly et al.,  1992; 
Gallant and Nigg, 1992; Ookata et al.,  1992). This translo- 
cation raises  two  interesting mechanistic  questions:  How 
does  p34~dCVcyclin B  release  from  microtubules  at  the 
G2/M border? In addition, does cyclin B's interaction with 
MAP4 and microtubules serve to direct a subset of p34  'd'~ 
kinase toward specific subcellular substrates at appropriate 
stages of mitosis? Association of p34  ¢dc2 kinase with chro- 
mosomes and nuclear lamina has also been demonstrated by 
the detection of histone H1 kinase activity and by immuno- 
blotting of isolated chromatin and nuclei  (Chambers  and 
Langan,  1990; Dessev et al.,  1991).  Each of these nuclear 
components shows dramatic structural or functional changes 
at the onset of mitosis, and each component is thought to 
possess proteins that are substrates for phosphorylation by 
p34~dcVcyclin B kinase. Our results raise the possibility that 
cyclin B  generally  serves  to  anchor  the  p34~dc2/cyclin B 
complex to the specific subcellular structures on which it 
must act in order to drive the cell from an interphase to a 
mitotic state. 
Possible Phosphorylation Sites of  MAP4 
by p34  c~2 Kinase 
Microtubule dynamics is generally thought to be regulated 
by MAPs (Olmsted,  1986; Pryer et al.,  1992). Heat stable 
brain  MAPs,  MAP2  and tau,  as  well as  MAP4,  contain 
three, four,  or five imperfect repeated sequences in their 
microtubule assembly promoting region near their carboxy- 
termini (see Chapin and Bulinski, 1992 for a review, Aizawa 
et al.,  1990; West et al.,  1991; Chapin et al.,  1994). Phos- 
phorylation of MAP2 and tau proteins has been shown to re- 
duce  their  microtubule  stabilizing  ability  (Lindwall  and 
Cole,  1984;  Faruki  et al.,  1992;  Drechsel et al.,  1992). 
Since MAP4 is the predominant MAP in HeLa cells (Bulin- 
ski and Borisy, 1980a), and it is known to be phosphorylated 
at mitosis (Tombes et al., 1991; Vandre et al., 1991), we sus- 
pected that MAP4 phosphorylation might be responsible for 
modulating microtubule dynamics at M-phase. In support of 
this notion, Olmsted et al. (1989)  previously demonstrated 
from FRAP analysis of fluorescent-labeled MAP4 microin- 
jected into cultured cells that the rate of MAP4 exchange on 
microtubules is a function of time in the cell cycle. 
In this work, we have tested the hypothesis that p34  cdc2 ki- 
nase directly affects the  microtubule-stabilizing ability of 
MAP4 by phosphorylating the MAP at mitosis. Association 
of p34  cd~2 kinase with MAP4 in vitro and probably in vivo 
suggests that this hypothesis is likely. Further support for this 
hypothesis derives from our demonstration that (a) MAP4 
did become phosphorylated in microtubule fractions by a 
microtubule-associated historic H1  kinase that is likely to 
correspond to p34  ~c2 kinase;  (b) purified p34c~c2/cyclin B 
kinase efficiently  phosphorylated purified MAP4 in vitro and 
PA4 in a  ternary complex of p34cdc2/cyclin B/PA4; and (c) 
phosphorylation by  p34  ~d¢2 kinase  reduced  the  ability  of 
MAP4 to stabilize microtubules, consistent with the increase 
in microtubule dynamics that has been noted in mitotic cells 
(Salmon et al.,  1984). 
The sequence (Ser/Thr)-Pro-X-(Lys/Arg) is generally ac- 
cepted to be the phosphorylation consensus  sequence for 
p34  ~d¢2 kinase  (Moreno and Nurse,  1990).  There are two 
consensus sequences for phosphorylation by p34  ¢d¢2 kinase 
within the Pro-rich region of MAP4 (enclosed in boxes in 
Fig. 9); in contrast, no such sequence is present in the AP 
sequence region.  These two Ser-Pro-X-Lys sequences are 
completely conserved among  human,  bovine and  mouse 
MAP4, while the Ser-Pro and Thr-Pro sequences (indicated 
by double underlines in Fig. 9), which were initially sug- 
gested as putative phosphorylation sites in bovine MAP4 by 
Aizawa  et  al.  (1991b),  are  not  found  in  human  MAP4 
(Aizawa et al., 1990; Chapin and Bulinski, 1991; West et al., 
Ookata  et  al. Association and Phosphorylation of MAP4 with p34  ~c2 Kinase  859 1991).  Preliminary results using antibodies that recognize 
the phosphorylated form of these putative phosphorylation 
sites  suggest  that  one  or  both  of these  is  indeed  phos- 
phorylated during mitosis  (our unpublished observation). 
Further studies will be needed in order to establish whether 
phosphorylation of SPXK sites is crucial for the M-phase 
regulation of MAP4 function. 
MAP4 has been reported to be phosphorylated by protein 
kinase C (Mori et al., 1991) and MAP kinase (Hoshi et al., 
1992) and phosphorylation by either kinase decreases the 
ability of MAP4 to stimulate polymerization  of microtubules 
in vitro. The protein kinase C-phosphorylation site has been 
shown to be within the Pro-rich region (Mori et al.,  1991). 
It  is  reasonable  to  expect  that  introduction  of negative 
charges into the Pro-rich region by phosphorylation might 
result in a suppression of the microtubule-stabilizing ability 
of MAP4. 
MAP4 Stabih'zes Microtubules by Enhancing 
the Rescue Frequency and Phosphorylation by p34  c~2 
Kinase Diminishes Its Stabilizing Effect 
We have documented the effects of MAP4 on microtubule 
dynamics, for the first time. MAP4 concentrations used were 
insufficient  to  stimulate  microtubule  polymerization ini- 
tially;  the  24-26°C  temperature of observation  was  also 
relatively  unfavorable  for  microtubule-polymerization. 
Therefore, in our experiments both the rate of microtubule- 
polymerization and  the  frequency of rescue  events  were 
lower than those obtained by Walker et al. (1988). However, 
even under these conditions, HeLa MAP4 strongly stabilized 
microtubules, and this stabilization was shown to be mainly 
due to the increase in rescue frequency at the plus end of 
microtubules. 
In contrast to results with unphosphorylated MAP4, mi- 
crotubules  depolymerized completely in  the  presence  of 
phosphorylated MAP4. Although this result is overtly simi- 
lar to results obtained with microtubules devoid of bound 
MAP4, we found that MAP4 phosphorylation did not lead 
to a complete loss of binding of MAP4 to microtubules. The 
occurrence of a reduced frequency of rescue in the presence 
of bound, phosphorylated MAP4 is in contrast to the com- 
plete lack of rescue in the absence of MAP4. It is possible 
that  MAP4  phosphorylation  decreases  the  microtubule- 
stabilizing ability of MAP4 by reducing its affinity to bind 
microtubules, as was  suggested to occur with tau protein 
(Drechsel et al.,  1992). If MAP4's affinity for microtubules 
were  reduced,  the  MAP might be ineffective at stopping 
microtubule depolymerization, regardless of the fact that it 
was still bound to microtubules. Moreover, a lower affinity 
of binding could decrease the number (density) of MAP4 
molecules on microtubules and, as a result, the shortening 
distance (perhaps the distance between MAP4 molecules on 
the microtubule) would increase. 
The decrease in  MAP4's  microtubule-stabilizing ability 
brought about by phosphorylation was shown to correspond 
to a decrease in the frequency of rescue at the plus end of 
microtubules. Other dynamic parameters were not similarly 
affected by phosphorylation. In particular, those of the minus 
end appeared relatively insensitive to the presence or ab- 
sence of MAPs (Itoh and Hotani,  1994)  and to the phos- 
phorylation of MAP4.  A  similar  decrease in  rescue  fre- 
quency was reported by Verde et al. (1992) with Xenopus egg 
extracts that were brought to mitotic phase from interphase 
by addition of cyclin B or cyclin A, as well as by Glicksman 
et al. (1992) with sea urchin egg extract that was induced to 
a mitotic-like state by okadaic acid. In other words, phos- 
phorylation of MAP4 by p34  cat2 kinase apparently renders 
MAP4-stabilized microtubules more dynamic, analogous to 
what has been observed for mitotic microtubules by microin- 
jection of fluorescently labeled tubulin (Salmon et al., 1984; 
Hamaguchi et al., 1985; Belmont et al.,  1990; Verde et al., 
1992) and MAPs (MAP4 and MAP2) (Olmsted et al., 1989). 
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